Market Resilience Analysis: Nifty Recovers to 25,482 as IT and Metals Surge Amid Global Trade Volatility

Introduction

Indian equity markets displayed remarkable resilience on Wednesday, February 25, 2026, as benchmark indices staged a recovery from the steep losses witnessed in the previous session. The Sensex closed marginally higher at 82,276.07 (+52 points, +0.06%), while the Nifty 50 advanced 57.85 points (+0.23%) to settle at 25,482.50. This recovery was particularly notable as the Nifty trimmed substantial intraday gains that had earlier reached as high as 682 points before settling into a more consolidated range.

The day’s trading encapsulated a complex interplay of global trade tensions, sectoral rotations, and significant regulatory policy battles. Data suggests a sharp divergence across sectors; while the Nifty IT index surged over 3% to lead the recovery, the solar energy segment faced a brutal selloff following punitive US tariffs. Beneath these headline moves, significant corporate actions—including a major government divestment in IRFC and transformative pharmaceutical developments—revealed deeper structural changes currently underway in the Indian economy.

The IT Sector Phoenix: Rising from AI's Ashes

The Anthropic Shock and Recovery

The Indian information technology sector has endured a turbulent period in February 2026, driven by existential fears regarding Artificial Intelligence (AI) disruption. The primary catalyst was Anthropic’s launch of advanced AI tools via its Claude platform, which demonstrated capabilities in automating professional tasks such as contract reviews and legal functions. These are core services that have sustained India’s IT export model for decades.

However, on February 25, the sector staged a dramatic comeback. The Nifty IT index surged 3.14%, following a brutal 4.7% single-day decline on February 24. This recovery is significant given that the sector lost approximately $68.6 billion in market capitalization during the first half of February 2026.

FII Flows: The Turning Tide

Historical trends indicate a critical shift in Foreign Institutional Investor (FII) behavior. After being net sellers of ₹10,956 crore worth of IT stocks in the first 15 days of February—pushing FII holdings to a four-year low of ₹4.49 lakh crore—foreign investors turned net buyers in the latter half of the month. This reversal injected ₹3,843 crore back into Indian equities, providing much-needed support.

IT Sector Valuation Multiples (Feb 25, 2026)

CLSA recently initiated coverage on TCS with an Outperform rating and a target price of ₹3,593, implying a 39% upside. The brokerage highlighted TCS’s partnership with ServiceNow to build industry-specific AI solutions for back-office functions as a key driver for transforming manual processes into autonomous workflows.

The Regulatory Battleground: RBI vs. Brokerage Industry

A Liquidity Squeeze in the Making

A significant policy confrontation emerged this week as stockbroker associations, including ANMI, BBF, and CPAI, met with the Department of Economic Affairs. They are seeking a minimum six-month extension on new RBI funding norms set to take effect on April 1, 2026.

The RBI circular, issued February 13, requires banks to implement 100% collateralization for capital market exposures, a massive jump from the current 50%. Furthermore, daily exposure for banks is now capped at 15% of Settlement Guarantee Fund (SGF) liquid assets for AAA-rated banks and 10% for AA-rated institutions.

Market Impact Concerns

Brokers argue that the timing is critical, as these norms coincide with the increased Securities Transaction Tax (STT) on options trading. Industry participants warned that the dual implementation could mirror South Korea’s derivatives market collapse. SEBI Chairman Tuhin Kanta Pandey acknowledged that the regulator would examine the issues, though RBI Governor Sanjay Malhotra has stated the central bank would not provide further relaxation beyond the easing already provided in the final guidelines.

Global Trade Tensions: The Trump Tariff Tempest

India's "Middle Ground" and Solar Sector Impact

India’s trade position has evolved into a "middle ground" following the reimposition of US Section 122 tariffs. While a baseline 10% across-the-board levy represents an improvement over earlier threats, the impact on specific sectors has been devastating. On February 25, the US Department of Commerce imposed preliminary countervailing duties of 126% on solar imports from India.

Solar Stock Performance (Feb 25, 2026)

President Trump has indicated that tariffs could increase to 15% within the next 150 days, creating a significant headwind for Indian exporters who utilize the US as a primary market.

The Metal Sector Resurgence: Steel’s Shining Moment

In stark contrast to the solar rout, the Nifty Metal index rallied 2.2% to 3%, becoming the top-performing sectoral gauge. This surge was led by the "Steel Triumvirate" hitting all-time highs simultaneously.

Metal Sector Highlights

• Tata Steel: Reached a fresh peak of ₹216.35 (up 3%).
• JSW Steel: Hit a record ₹1,266.80 (up 2%).
• Jindal Steel: Touched an all-time high of ₹1,258.50 (up 2%).
• Vedanta: Rallied 5% to close at ₹732.35 after BofA Securities upgraded the stock to Buy with a ₹840 target price (a 75% increase from the previous ₹480 target).

Fundamental support came from the Ministry of Steel, which reported 9.9% Year-on-Year (YoY) growth in January 2026 production. Additionally, Vedanta’s board approved an NCD fundraise of up to ₹3,000 crore, emphasizing that there has been no delay in interest or principal payments to date.

The Pharmaceutical Revolution: Generic Semaglutide

A transformative shift is approaching the healthcare sector as Novo Nordisk’s patent on semaglutide (the API in Wegovy and Ozempic) expires on March 20, 2026. Generic launches are scheduled for March 21.

Investors may consider monitoring the following players preparing for the launch:

• Sun Pharma: Committing to prefilled pen formats and ensuring domestic supply.
• Natco Pharma: Secured CDSCO approval for various dosages and partnered with Eris Lifesciences.
• Dr. Reddy’s, Cipla, and Zydus Lifesciences: Preparing distribution networks for the generic wave.

Generic versions are expected to cost ₹3,500 - ₹4,000 per month, approximately 50% cheaper than the current ₹10,000 price point for innovator brands. Analysts project this ₹1,400 crore market could grow ten-fold over the next few years.

Corporate Actions and Capital Market Events

IRFC Divestment and Technical Pressure

The Government of India initiated an Offer for Sale (OFS) of a 4% stake in IRFC at a floor price of ₹104 per share. This represents a 5% discount to the previous close. The technical supply event caused the stock to plunge 4.2% to an intraday low of ₹104.82, a 25-month low.

Brokerage and Banking Developments

• Angel One: Set February 26 as the record date for its 1:10 stock split, reducing face value from ₹10 to ₹1.
• Canara Bank: Planning to raise ₹5,000 crore via Basel III-compliant Tier 2 bonds to support a revised loan growth guidance of 13-15%.
• SpiceJet: Shares crashed 10% to an 11-year low of ₹12.88 after block deals involving 8.4% of equity (15 crore shares) changed hands.

IPO and Infrastructure Highlights

IPO Market Demand

L&T’s Major Wins

Larsen & Toubro secured two landmark orders:

1. LIGO India Project: ₹1,000 - ₹2,500 crore for high-precision civil infrastructure for the gravitational-wave observatory.
2. Power PT&D: ₹5,000 - ₹10,000 crore for 250+ km of transmission lines across India and the Middle East.

Technical Outlook and Market Support

Technical analysts highlight that while the intraday texture remains volatile, key support and resistance levels are clearly defined for the current cycle:

• Nifty Support: 25,300 - 25,400 range.
• Nifty Resistance: 25,850 - 26,000 zone.
• Bank Nifty: Immediate resistance at 61,400 - 61,500.
• Sensex Support: The 82,000 level remains critical to avoid a fresh selloff.

Global sentiment will be heavily influenced by Nvidia’s Q4 FY26 earnings (expected revenue of $66.16 billion), which acts as the ultimate test for the sustainability of the AI infrastructure boom.

Key Takeaways

• IT Rebound: The Nifty IT index's 3.14% rise suggests the "Anthropic Shock" may be priced in, with FIIs returning as buyers (₹3,843 crore inflow).
• Metal Strength: Steel majors hitting all-time highs and Vedanta's 75% target price hike signal strong cyclical demand.
• Trade Risks: The 126% US duty on solar imports and the impending 150-day tariff clock present a major challenge for Indian exporters.
• Policy Standoff: Brokers are bracing for the April 1 implementation of 100% collateral norms, which could impact intraday liquidity.
• Pharma Catalyst: The March 21 launch of generic weight-loss drugs is set to democratize a market currently growing at 15% monthly.

What This Means for Investors

Investors may consider a nuanced approach rather than broad-market sentiment. Data suggests that while large-cap indices like the Nifty and Sensex are consolidating, sectoral rotation is providing significant opportunities. The outperformance of PSU Banks and Metals over traditional private sector banks and solar energy highlights the importance of monitoring policy shifts and global trade negotiations.

Historical trends indicate that stock splits (like Angel One) and divestments (like IRFC) often create temporary price volatility that may take several weeks to stabilize. Furthermore, the Union Budget 2026-27 allocations for the Biopharma Shakti program and infrastructure thrust provide long-term tailwinds for the pharmaceutical and engineering sectors respectively.